USD 305.11
(0.95%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 9.20 USD | 21.53% |
2022 | 7.57 USD | 49.6% |
2021 | 5.06 USD | 24.32% |
2020 | 4.07 USD | 45.88% |
2019 | 2.79 USD | 36.1% |
2018 | 2.05 USD | 105.0% |
2017 | 1.00 USD | 163.16% |
2016 | 0.38 USD | 235.71% |
2015 | -0.28 USD | 47.17% |
2014 | -0.53 USD | -139.85% |
2013 | 1.33 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | 3.11 USD | 9.12% |
2024 Q2 | 2.85 USD | -14.16% |
2024 Q1 | 3.32 USD | 30.2% |
2023 Q3 | 2.30 USD | 15.0% |
2023 Q2 | 2.00 USD | -14.89% |
2023 Q1 | 2.35 USD | 6.82% |
2023 FY | - USD | 21.53% |
2023 Q4 | 2.55 USD | 10.87% |
2022 Q3 | 2.13 USD | 40.13% |
2022 Q1 | 1.75 USD | 25.9% |
2022 FY | - USD | 49.6% |
2022 Q4 | 2.20 USD | 3.29% |
2022 Q2 | 1.52 USD | -13.14% |
2021 Q1 | 1.21 USD | -14.79% |
2021 FY | - USD | 24.32% |
2021 Q2 | 1.11 USD | -8.26% |
2021 Q4 | 1.39 USD | 2.96% |
2021 Q3 | 1.35 USD | 21.62% |
2020 Q3 | 1.16 USD | 70.59% |
2020 FY | - USD | 45.88% |
2020 Q4 | 1.42 USD | 22.41% |
2020 Q2 | 0.68 USD | -15.0% |
2020 Q1 | 0.80 USD | -2.44% |
2019 Q1 | 0.54 USD | -15.63% |
2019 FY | - USD | 35.44% |
2019 Q4 | 0.82 USD | 22.39% |
2019 Q3 | 0.67 USD | -11.84% |
2019 Q2 | 0.76 USD | 40.74% |
2018 Q3 | 0.54 USD | 17.39% |
2018 FY | - USD | 106.0% |
2018 Q4 | 0.64 USD | 18.52% |
2018 Q2 | 0.46 USD | 12.2% |
2018 Q1 | 0.41 USD | 32.26% |
2017 Q4 | 0.31 USD | 24.0% |
2017 Q3 | 0.25 USD | 4.17% |
2017 Q2 | 0.24 USD | 14.29% |
2017 Q1 | 0.21 USD | 42100.0% |
2017 FY | - USD | 163.16% |
2016 Q3 | 0.14 USD | -6.67% |
2016 Q4 | -0.00 USD | -100.36% |
2016 FY | - USD | 272.73% |
2016 Q2 | 0.15 USD | 36.36% |
2016 Q1 | 0.11 USD | 140.74% |
2015 Q4 | -0.27 USD | -6328.57% |
2015 Q3 | -0.00 USD | -240.0% |
2015 Q2 | 0.00 USD | 257.89% |
2015 Q1 | -0.00 USD | 0.0% |
2015 FY | - USD | 58.49% |
2014 FY | - USD | -181.54% |
2014 Q1 | -0.03 USD | 0.0% |
2013 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aclaris Therapeutics, Inc. | -1.27 USD | 824.409% |
Applied DNA Sciences, Inc. | -15.21 USD | 160.487% |
Aspira Women's Health Inc. | -1.81 USD | 608.287% |
Biodesix, Inc. | -0.64 USD | 1537.5% |
BioNexus Gene Lab Corp. | -0.17 USD | 5511.765% |
bioAffinity Technologies, Inc. | -0.91 USD | 1110.989% |
bioAffinity Technologies, Inc. | -0.91 USD | 1110.989% |
Bionano Genomics, Inc. | -6.81 USD | 235.095% |
CareDx, Inc | -3.54 USD | 359.887% |
Check-Cap Ltd. | -3.00 USD | 406.667% |
Castle Biosciences, Inc. | -2.14 USD | 529.907% |
DarioHealth Corp. | -1.93 USD | 576.684% |
Exact Sciences Corporation | -1.13 USD | 914.159% |
Fulgent Genetics, Inc. | -5.63 USD | 263.41% |
Guardant Health, Inc. | -4.28 USD | 314.953% |
ICON Public Limited Company | 7.46 USD | -23.324% |
IDEXX Laboratories, Inc. | 10.17 USD | 9.538% |
Illumina, Inc. | -7.35 USD | 225.17% |
Intelligent Bio Solutions Inc. | -6.38 USD | 244.201% |
iSpecimen Inc. | -1.23 USD | 847.967% |
Standard BioTools Inc. | -0.94 USD | 1078.723% |
MDxHealth SA | -1.66 USD | 654.217% |
23andMe Holding Co. | -1.40 USD | 757.143% |
Myriad Genetics, Inc. | -1.39 USD | 761.871% |
Mainz Biomed B.V. | -1.62 USD | 667.901% |
ENDRA Life Sciences Inc. | -1.11 USD | 928.829% |
NeoGenomics, Inc. | -0.70 USD | 1414.286% |
Neogen Corporation | -0.04 USD | 21249.425% |
Inotiv, Inc. | -4.10 USD | 324.39% |
Natera, Inc. | -3.78 USD | 343.386% |
OPKO Health, Inc. | -0.25 USD | 3780.0% |
Psychemedics Corporation | -0.72 USD | 1377.778% |
Prenetics Global Limited | -5.58 USD | 264.875% |
Prenetics Global Limited | -5.58 USD | 264.875% |
Precipio, Inc. | -4.51 USD | 303.991% |
Personalis, Inc. | -2.25 USD | 508.889% |
RadNet, Inc. | 0.05 USD | -19106.681% |
Sera Prognostics, Inc. | -1.16 USD | 893.103% |
Sotera Health Company | 0.18 USD | -5011.111% |
Neuronetics, Inc. | -1.05 USD | 976.19% |
Star Equity Holdings, Inc. | 7.42 USD | -23.989% |
Star Equity Holdings, Inc. | 7.42 USD | -23.989% |
Trinity Biotech plc | -3.14 USD | 392.994% |
Twist Bioscience Corporation | -3.60 USD | 355.556% |
Exagen Inc. | -1.34 USD | 786.567% |